Insights from 2023 ESMO Annual Meeting
S

ESMO 2023 Insights: "Phase 3 DUO-E/GOG-3041/ENGOT-EN10 Trial - Durvalumab + Carboplatin/Paclitaxel Followed by Maintenance Durvalumab±Olaparib for Newly Diagnosed Advanced/Recurrent Endometrial Cancer"

By Insights from 2023 ESMO Annual Meeting FEATURING Shannon Westin
By Insights from 2023 ESMO Annual Meeting FEATURING Shannon Westin
269 views
October 26, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
15:14
Brian Slomovitz

Update in Vulvar and Vaginal Cancer

08:45
Total Health

Recent Highlights in Endometrial Cancer

Feat. B. Slomovitz
08:16
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "GOG-0258 - OS by Molecular Classification W…

Feat. A. Clements
16:37
Total Health

2024 Updates in Uterine/Endometrial Cancer

Feat. T. Tillmanns
10:35
UCLA Health

Updates in Endometrial Cancer

Feat. R. Salani
07:24
Fengting Yan

Year in Review: Endometrial Cancer

44:59
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Updates on Cervical and Endometrial Cancers

Feat. K. Pennington
11:19
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "RUBY Part 1 & Part 2 Trial - Dostarlima…

Feat. M. Raza Mirza
07:25
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "The Use of Rucaparib vs. Placebo Maintenanc…

Feat. B. Corr
27:12
OncoAlert

New Endometrial Cancer FIGO Staging System in the Era of Molecular C…

Feat. N. Concin
18:46
OncoAlert

Systemic Therapies for Uterine Leiomyosarcoma

Feat. I. Ray-Coquard
09:29
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "Phase 3 RUBY Trial - Dostarlimab + Chemoth…

Feat. M. Raza Mirza
12:55
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024

Integrating Immunotherapy Into the Treatment of Endometrial Cancer

Feat. A. Wright
05:32
Insights from 2023 ESMO Asia Annual Meeting

LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…

Feat. N. Ngoi
10:27
Robert McBane

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…

16:40
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Latest Clinical Trial Updates That Have Ch…

Feat. C. Marth
10:43
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "Are We Changing the History of Endometrial…

Feat. M. Raza Mirza
12:21
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "PARP Inhibitor Resistance Mechanisms in Gy…

Feat. V. Heinzelmann-Schwarz